Jan 09, 2023 / 06:30PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Thanks, everyone. I'm Robbie Marcus, the Medtech analyst at JPMorgan. Thanks for joining. Happy to have our next session, Penumbra. I'm going to introduce Adam Elsesser, the CEO, and then we'll do a little Q&A after. Adam?
Adam Elsesser - Penumbra, Inc. - Co-Founder, Chairman, President & CEO
Thank you. Good morning. It is actually great to be back in person. This year's 41st annual JPMorgan Healthcare Conference, navigating the hallways. I want to thank JPMorgan for inviting us and of course, Robbie, for your coverage of Penumbra. Toward the end of the presentation today, I'll be playing some videos. If you're listening to this presentation via the webcast, you can view the slide deck and play the videos by going to our website under the Investor Relations heading since they won't be able to be seen through the webcast. And I appreciate your understanding on that. I'm just trying to see here where the buttons are for the slide thing. Here we go. That's our safe harbor statement.
Penumbra Inc at JPMorgan Healthcare Conference Transcript
Feb 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers